Skip to main content
. 2023 Feb 21;15(5):1357. doi: 10.3390/cancers15051357

Figure 6.

Figure 6

Aptamer CAR-T-cell technology. Construction of universal CAR-T cells expressing nontumor-associated antigens, such as fluorescein isothiocyanate (FITC)-CAR-T cells, targeting multiple target antigens on the surface of tumor cells through a mixture of bispecific aptamers. Illustration was created with Biorender.com.